Crossmark

Vessel size and perfusion-derived vascular habitat refines prediction of treatment failure to bevacizumab in recurrent glioblastomas: validation in a prospective cohort

Crossref DOI link: https://doi.org/10.1007/s00330-022-09164-w

Published Online: 2022-10-15

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kim, Minjae

Park, Ji Eun https://orcid.org/0000-0002-4419-4682
Yoon, Shin Kyo

Kim, Nakyoung

Kim, Young-Hoon

Kim, Jeong Hoon

Kim, Ho Sung
Funding

Funding for this research was provided by:

National Research Foundation of Korea (NRF-2020R1A2B5B01001707)

National Research Foundation of Korea (NRF-2020R1A2C4001748)
License Information

Text and Data Mining valid from 2022-10-15

Version of Record valid from 2022-10-15
More Information

Article History

Received: 18 April 2022

Revised: 23 July 2022

Accepted: 11 September 2022

First Online: 15 October 2022

Declarations

:

: The scientific guarantor of this publication is Ji Eun Park.

: The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.

: One of the authors (J.E. Park) has significant statistical expertise.

: Written informed consent was waived by the Institutional Review Board.

: Institutional Review Board approval was obtained.

: • Retrospective with prospective validation• Diagnostic or prognostic study• Performed at one institution

Document is current

Any future updates will be listed below